Results 151 to 160 of about 111,384 (201)

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW).
Elizabeth Hastie   +10 more
wiley   +1 more source

Mimic, target, and adapt: Cell membrane‐coated nanoplatforms for precision and immune‐guided cancer treatment

open access: yesBMEMat, EarlyView.
This Perspective explores the emerging landscape of cell membrane‐coated nanoparticles (CM‐NPs) as intelligent, immune‐compatible platforms for cancer therapy. Highlighting design strategies, translational challenges, and competitive positioning, it outlines how integrating biomimetic targeting with advanced analytical and manufacturing tools could ...
A. K. M. M. Alam   +4 more
wiley   +1 more source

Liquid Biopsy Frontiers in Pancreatic Cancer: Insights from Circulating Cell-Free Nucleic Acids. [PDF]

open access: yesCells
Latiano M   +11 more
europepmc   +1 more source

Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. [PDF]

open access: yesCurr Issues Mol Biol
Kaštelan S   +4 more
europepmc   +1 more source

Liquid biopsy in cancer diagnosis and prognosis: a paradigm shift in precision oncology. [PDF]

open access: yesFront Mol Biosci
Abreu RDS   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy